Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers
Biomolecules · 2023
DOI: 10.3390/biom13081184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Ning Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Carcinogenesis, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Science and Technological Supports Project of Sichuan Province, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Liver X receptor α (LXRα), a member of the nuclear receptor superfamily, is identified as a protein activated by ligands that interacts with the promoters of specific genes. It regulates cholesterol, bile acid, and lipid metabolism in normal physiological processes, and it participates in the development of some related diseases. However, many studies have demonstrated that LXRα is also involved in regulating numerous human malignancies. Aberrant LXRα expression is emerging as a fundamental and pivotal factor in cancer cell proliferation, invasion, apoptosis, and metastasis. Herein, we outline the expression levels of LXRα between tumor tissues and normal tissues via the Oncomine and Tumor Immune Estimation Resource (TIMER) 2.0 databases; summarize emerging insights into the roles of LXRα in the development, progression, and treatment of different human cancers and their diversified mechanisms; and highlight that LXRα can be a biomarker and therapeutic target in diverse cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
- Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.
Förderung
- National Key Research and Development Program of China
- Science and Technological Supports Project of Sichuan Province
- 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
Zitieren
APA
Han, N., Yuan, M., Yan, L., & Tang, H. (2023). Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers. Biomolecules. https://doi.org/10.3390/biom13081184
Vancouver
Han N, Yuan M, Yan L, Tang H. Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers. Biomolecules. 2023. doi:10.3390/biom13081184
BibTeX
@article{Han2023,
author = {Han, Ning and Yuan, Man and Yan, Libo and Tang, Hong},
title = {Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13081184}
}
EUVIMED